raloxifene hydrochloride has been researched along with Adenocarcinoma in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (21.74) | 18.2507 |
| 2000's | 11 (47.83) | 29.6817 |
| 2010's | 6 (26.09) | 24.3611 |
| 2020's | 1 (4.35) | 2.80 |
| Authors | Studies |
|---|---|
| Bruns, CJ; Camaj, P; Hartmann, L; Hering, NA; Kreis, ME; Lee, LD; Liu, V; Müller, MH; Pozios, I; Seel, NN; Seeliger, H | 1 |
| Brewer, M; Bryant, T; Janakiram, NB; Lightfoot, S; Mohammed, A; Rao, CV; Steele, VE; Zhang, Y | 1 |
| Alexi, X; Alexis, MN; Fokialakis, N; Haroutounian, SA; Kasiotis, KM; Lambrinidis, G; Meligova, AK; Mikros, E | 1 |
| Atkins, JN; Bevers, TB; Cecchini, RS; Costantino, JP; Cronin, WM; Fehrenbacher, L; Ford, LG; Ganz, PA; James, J; Jordan, VC; Margolese, RG; McCaskill-Stevens, W; Pajon, ER; Reis, SE; Robidoux, A; Runowicz, CD; Vogel, VG; Wade, JL; Wickerham, DL; Wolmark, N | 1 |
| Brown, PH; Hortobagyi, GN | 1 |
| Ravdin, PM | 1 |
| Cuzick, J | 1 |
| Ansar, A; Hussey, DJ; Sukocheva, OA; Watson, DI; Wee, C | 1 |
| Burd, CJ; Feng, Y; Khan, SA; Singleton, DW | 1 |
| Amezcua, CA; Boostanfar, R; Felix, JC; Roy, S; Stanczyk, FZ; Tourgeman, DE | 1 |
| Cornella, JL; Hibner, M; Lefler, SR; Loftus, JC; Magrina, JF; Pizarro, AR | 1 |
| Haczynski, J; Jarzabek, K; Knapp, P; Koda, M; Sulkowski, S; Wolczynski, S | 1 |
| Chen, Y; Imaida, K; Kakehi, Y; Matsuda, Y; Saoo, K; Takeuchi, H; Yamakawa, K; Yokohira, M; Zeng, Y | 1 |
| Brown, PH; Uray, IP | 1 |
| Best, KL; Counts, DF; Goode, RL; Hoover, DM; Jones, CD; Merriman, RL; Neubauer, BL; Sarosdy, MF; Shaar, CJ; Tanzer, LR | 1 |
| Adrian, MD; Bryant, HU; Cho, S; Cole, HW; Finley, DR; Glasebrook, AL; Godfrey, AG; Grese, TA; Jones, CD; Lugar, CW; Magee, DE; Martin, MJ; Matsumoto, K; Pennington, LD; Phillips, DL; Rowley, ER; Short, LL; Winter, MA | 1 |
| Belanger, A; Gauthier, S; Labrie, C; Labrie, F; Merand, Y; Poirier, D; Sanchez, R; Simard, J; Singh, SM | 1 |
| Bryant, HU; Cho, S; Dodge, JA; Frolik, CA; Glasebrook, AL; Lugar, CW; Martin, MJ; Osborne, JJ; Phillips, DL; Sato, M; Short, LL; Spangle, LA; Yang, NN | 1 |
| Boersma, CJ; Dijkema, R; Mosselman, S; Mulder, WR; Olijve, W; van den Wijngaard, A; van Zoelen, EJ | 1 |
| Anchim, T; Dabrowska, M; Dziecioł, J; Swiatecka, J; Wołczyński, S | 1 |
| Mosca, L | 1 |
| Chen, B; Dardes, RC; Jordan, VC; Osipo, C; Pearce, ST; Schafer, JM | 1 |
| Bennett, JA; Bowser, SS; Bradley, L; Dickerman, HW; Gierthy, JF; Lincoln, DW; Roth, KE | 1 |
2 review(s) available for raloxifene hydrochloride and Adenocarcinoma
| Article | Year |
|---|---|
Prevention of breast cancer: current state of the science and future opportunities.
Topics: Adenocarcinoma; Adult; Aged; Animals; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Cyclooxygenase 2 Inhibitors; Double-Blind Method; Drug Evaluation, Preclinical; Drug Therapy, Combination; Estrogen Receptor Modulators; Estrogens; Female; Forecasting; Humans; Leuprolide; Mammary Neoplasms, Experimental; Mice; Middle Aged; Ovariectomy; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Rats; Retinoids; Selective Estrogen Receptor Modulators; Tamoxifen | 2006 |
Rationale and overview of the Raloxifene Use for the Heart (RUTH) trial.
Topics: Adenocarcinoma; Breast Neoplasms; Cardiovascular Diseases; Estrogen Replacement Therapy; Female; Humans; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators | 2001 |
2 trial(s) available for raloxifene hydrochloride and Adenocarcinoma
| Article | Year |
|---|---|
Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Breast Neoplasms; Cataract; Double-Blind Method; Drug Utilization; Endometrial Neoplasms; Estrogens; Female; Follow-Up Studies; Fractures, Spontaneous; Humans; Incidence; Middle Aged; Myocardial Ischemia; Neoplasm Invasiveness; Neoplasms, Hormone-Dependent; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Risk; Selective Estrogen Receptor Modulators; Tamoxifen; Thromboembolism; Uterus | 2010 |
Rationale and overview of the Raloxifene Use for the Heart (RUTH) trial.
Topics: Adenocarcinoma; Breast Neoplasms; Cardiovascular Diseases; Estrogen Replacement Therapy; Female; Humans; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators | 2001 |
20 other study(ies) available for raloxifene hydrochloride and Adenocarcinoma
| Article | Year |
|---|---|
Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signaling.
Topics: Adenocarcinoma; Animals; Cell Line, Tumor; Cell Proliferation; Cytokine Receptor gp130; Estrogen Receptor beta; Humans; Interleukin-6; Male; Mice, Nude; Neoplasm Metastasis; Pancreatic Neoplasms; Raloxifene Hydrochloride; Signal Transduction; STAT3 Transcription Factor; Time Factors; Xenograft Model Antitumor Assays | 2021 |
Chemopreventive efficacy of raloxifene, bexarotene, and their combination on the progression of chemically induced colon adenomas to adenocarcinomas in rats.
Topics: Adenocarcinoma; Adenoma; Adult; Aged; Animals; Anticarcinogenic Agents; Apoptosis; Azoxymethane; Bexarotene; Biomarkers, Tumor; Blotting, Western; Colonic Neoplasms; Drug Therapy, Combination; Estrogen Antagonists; Estrogen Receptor beta; Female; Humans; Immunoenzyme Techniques; Male; Middle Aged; Neoplasm Grading; Raloxifene Hydrochloride; Rats; Rats, Inbred F344; Real-Time Polymerase Chain Reaction; Retinoid X Receptors; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrahydronaphthalenes; Tissue Array Analysis; Tumor Cells, Cultured | 2013 |
Differential estrogen receptor subtype modulators: assessment of estrogen receptor subtype-binding selectivity and transcription-regulating properties of new cycloalkyl pyrazoles.
Topics: Adenocarcinoma; Binding Sites; Cell Line, Tumor; Estradiol; Humans; Male; Models, Molecular; Prostatic Neoplasms; Pyrazoles; Raloxifene Hydrochloride; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Transcription, Genetic | 2009 |
Two good choices to prevent breast cancer: great taste, less filling.
Topics: Adenocarcinoma; Breast Neoplasms; Drug Utilization; Endometrial Neoplasms; Estrogens; Female; Follow-Up Studies; Humans; Incidence; Meta-Analysis as Topic; Multicenter Studies as Topic; Neoplasms, Hormone-Dependent; Osteoporosis, Postmenopausal; Practice Patterns, Physicians'; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Risk Assessment; Risk Reduction Behavior; Selective Estrogen Receptor Modulators; Tamoxifen; Uterus | 2010 |
The lack, need, and opportunities for decision-making and informational tools to educate primary-care physicians and women about breast cancer chemoprevention.
Topics: Adenocarcinoma; Breast Neoplasms; Decision Support Techniques; Drug Utilization; Estrogens; Female; Humans; Incidence; Internet; Multicenter Studies as Topic; Neoplasms, Hormone-Dependent; Patient Education as Topic; Physicians, Family; Practice Patterns, Physicians'; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Risk Assessment; Risk Reduction Behavior; Selective Estrogen Receptor Modulators; Tamoxifen | 2010 |
Long-term follow-up in cancer prevention trials (It ain't over 'til it's over).
Topics: Adenocarcinoma; Breast Neoplasms; Double-Blind Method; Drug Utilization; Endometrial Neoplasms; Estrogens; Female; Follow-Up Studies; Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; Humans; Incidence; Multicenter Studies as Topic; Neoplasms, Hormone-Dependent; Papillomavirus Vaccines; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Risk Assessment; Risk Reduction Behavior; Sample Size; Selective Estrogen Receptor Modulators; Tamoxifen; Uterine Cervical Neoplasms | 2010 |
Effect of estrogen on growth and apoptosis in esophageal adenocarcinoma cells.
Topics: Adenocarcinoma; Apoptosis; Barrett Esophagus; Cadherins; Cell Count; Cell Culture Techniques; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Esophageal Neoplasms; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Female; Humans; Ki-67 Antigen; Male; Raloxifene Hydrochloride; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Tamoxifen | 2013 |
Nongenomic activity and subsequent c-fos induction by estrogen receptor ligands are not sufficient to promote deoxyribonucleic acid synthesis in human endometrial adenocarcinoma cells.
Topics: Adenocarcinoma; DNA; Endometrial Neoplasms; Enzyme Activation; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Gene Expression; Humans; Luciferases; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Mutation; Proto-Oncogene Mas; Proto-Oncogene Proteins c-fos; Raloxifene Hydrochloride; Receptors, Estrogen; Recombinant Fusion Proteins; Response Elements; Tamoxifen; Transfection; Tumor Cells, Cultured | 2003 |
Growth effects of raloxifene, estradiol, medroxy-progesterone acetate, and progesterone on human endometrial adenocarcinoma cells.
Topics: Adenocarcinoma; Cell Division; Endometrial Neoplasms; Estradiol; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone Acetate; Progesterone; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tumor Cells, Cultured | 2003 |
Effects of raloxifene hydrochloride on endometrial cancer cells in vitro.
Topics: Adenocarcinoma; Cell Division; Cell Line, Tumor; Endometrial Neoplasms; Estradiol; Female; Humans; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators | 2004 |
Differential effects of raloxifene and tamoxifen on the expression of estrogen receptors and antigen Ki-67 in human endometrial adenocarcinoma cell line.
Topics: Adenocarcinoma; Antineoplastic Agents, Hormonal; Cell Division; Cell Line, Tumor; Endometrial Neoplasms; Estrogen Antagonists; Female; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Ki-67 Antigen; Raloxifene Hydrochloride; Receptors, Estrogen; Tamoxifen | 2004 |
Inhibition of prostate carcinogenesis in probasin/SV40 T antigen transgenic rats by raloxifene, an antiestrogen with anti-androgen action, but not nimesulide, a selective cyclooxygenase-2 inhibitor.
Topics: Adenocarcinoma; Androgen Antagonists; Androgen-Binding Protein; Animals; Animals, Genetically Modified; Antigens, Polyomavirus Transforming; Apoptosis; Cell Proliferation; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Drug Therapy, Combination; Male; Prostaglandin-Endoperoxide Synthases; Prostatic Neoplasms; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Receptors, Androgen; Sulfonamides; Testosterone | 2005 |
Raloxifene (LY156758) produces antimetastatic responses and extends survival in the PAIII rat prostatic adenocarcinoma model.
Topics: Adenocarcinoma; Adrenal Glands; Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Fluorouracil; Incidence; Lung Neoplasms; Lymphatic Metastasis; Male; Organ Size; Piperidines; Prostate; Prostatic Neoplasms; Raloxifene Hydrochloride; Random Allocation; Rats; Rats, Wistar; Survival Rate; Testis; Weight Gain | 1995 |
Structure-activity relationships of selective estrogen receptor modulators: modifications to the 2-arylbenzothiophene core of raloxifene.
Topics: Adenocarcinoma; Animals; Binding Sites; Bone and Bones; Breast Neoplasms; Cell Division; Cholesterol; Estrogen Antagonists; Female; Humans; Male; Organ Size; Ovariectomy; Piperidines; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Structure-Activity Relationship; Uterus | 1997 |
Blockade of the stimulatory effect of estrogens, OH-tamoxifen, OH-toremifene, droloxifene, and raloxifene on alkaline phosphatase activity by the antiestrogen EM-800 in human endometrial adenocarcinoma Ishikawa cells.
Topics: Adenocarcinoma; Alkaline Phosphatase; Benzopyrans; Endometrial Neoplasms; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Humans; Neoplasm Proteins; Piperidines; Propionates; Raloxifene Hydrochloride; Tamoxifen; Toremifene; Tumor Cells, Cultured | 1997 |
Evaluation of the major metabolites of raloxifene as modulators of tissue selectivity.
Topics: Adenocarcinoma; Animals; Bone Resorption; Breast Neoplasms; Cell Division; Cells, Cultured; Estradiol; Estrogen Antagonists; Female; Glucuronates; Humans; Interleukin-6; Organ Specificity; Osteoclasts; Ovariectomy; Piperidines; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Tissue Distribution; Transforming Growth Factor beta; Tumor Cells, Cultured | 1997 |
Antiestrogens specifically up-regulate bone morphogenetic protein-4 promoter activity in human osteoblastic cells.
Topics: Adenocarcinoma; Base Sequence; Bone Morphogenetic Protein 4; Bone Morphogenetic Proteins; Bone Neoplasms; Breast Neoplasms; Cells, Cultured; Dimerization; Drug Design; Endometrial Neoplasms; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogen Receptor Modulators; Estrogens; Female; Gene Expression Regulation; Humans; Molecular Sequence Data; Neoplasms, Hormone-Dependent; Organ Specificity; Osteoblasts; Osteogenesis; Osteoporosis; Osteosarcoma; Postmenopause; Promoter Regions, Genetic; Raloxifene Hydrochloride; Receptors, Estrogen; Recombinant Fusion Proteins; Stimulation, Chemical; Transfection; Tumor Cells, Cultured | 2000 |
[Biochemical mechanism of raloxifen and tamoxifen action for the prevention of breast cancer. Studies in vitro].
Topics: Adenocarcinoma; Apoptosis; Breast Neoplasms; Cell Division; Estrogen Antagonists; Female; Humans; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen; Tumor Cells, Cultured | 2000 |
Regulation of estrogen target genes and growth by selective estrogen-receptor modulators in endometrial cancer cells.
Topics: Adenocarcinoma; Animals; Blotting, Northern; Cell Division; Endometrial Neoplasms; Endothelial Growth Factors; ErbB Receptors; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogen Receptor Modulators; Female; Luciferases; Lymphokines; Mice; Mice, Nude; Neoplasm Transplantation; Proteins; Raloxifene Hydrochloride; Receptor, ErbB-2; Receptors, Estrogen; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Selective Estrogen Receptor Modulators; Tamoxifen; Transcription, Genetic; Trefoil Factor-1; Tumor Suppressor Proteins; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2002 |
Estrogen-stimulation of postconfluent cell accumulation and foci formation of human MCF-7 breast cancer cells.
Topics: Adenocarcinoma; Animals; Breast Neoplasms; Cattle; Cell Division; Contact Inhibition; Culture Media; Estradiol; Estrogens; Humans; Male; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Neoplasms, Hormone-Dependent; Phenotype; Piperidines; Raloxifene Hydrochloride; Receptors, Estrogen; Tamoxifen; Tumor Cells, Cultured | 1991 |